Abpro logo

Abpro(OTC) ABPWW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-99%
5 YearN/A
1 Year-93%
1 Month-19%
$0.00
+0.00%
+0.00Today
Abpro last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-11
Abpro stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-01
1 month-19.23%USD 0.002026-07-28
3 month-16%USD 0.002026-06-12
Year to date-87.2%USD 0.022025-12-31
1 year-93.23%USD 0.032025-09-11
3 year-94.87%USD 0.042023-09-05
Since inception-98.95%USD 0.202022-03-07

Abpro Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$2.01M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

2,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.03

Estimated Earnings Date

Aug 14, 2026

ABPWW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abpro

Abpro Holdings Inc. is a biotechnology firm focused on developing advanced antibody-based therapies for immuno-oncology, ophthalmology, and autoimmune disorders. The company leverages its innovative DiversImmune platform to address significant challenges in the antibody therapeutics market.

Products and Services
  • ABP-100 targets breast, gastric, and colorectal cancers
  • ABP-201 is designed for treating vascular conditions in the eye
  • Collaborations with Abpro Bio Co. Ltd and NJCTTQ enhance research capabilities
Growth Outlook
  • Established in 2004, the company has a long history in biotechnology
  • Recent advancements in antibody therapies position the company for future growth
  • Strategic partnerships may lead to expanded market opportunities
Financial Highlights
  • Q2 2026 net income of -$940,000 reflects ongoing investment in R&D
  • Cash and cash equivalents totaled $4.236 million as of June 30, 2026
  • Trailing twelve months (TTM) P/E ratio stands at 0.185, indicating potential value
Abpro Holdings Inc. is dedicated to addressing critical health challenges through its innovative therapies. The company's focus on research and development, combined with strategic partnerships, positions it well for future growth in the biotechnology sector. Recent financial data indicates ongoing investments in research, which may lead to significant advancements in its product pipeline. The current cash position provides a foundation for continued operations and development efforts.
AI Generated • Sep 23, 2026

Industry

Biotechnology

Headquarters

Burlington, MA 01803, US

ABPWW Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-35.79%

Return on Capital

-5749.66%

Return on Assets

38.37%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

2.00K

Avg. Volume

1.85K

Financials (TTM)

Gross Profit

$290.00K

Operating Income

-$5.34M

EBITDA

$4.00M

Operating Cash Flow

-$6.04M

Capital Expenditure

$0.00

Free Cash Flow

-$6.04M

Cash & ST Invst.

$4.24M

Total Debt

$171.00K

Abpro Performance Analysis

Abpro sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
Abpro sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3059.6%
Q42025-12-31622.2%
Q12026-03-31-107.0%
Q22026-06-3030.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$2.00K

+98.6%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

6

N/A

Net Income

-$940.00K

+68.5%

EBITDA

-$1.17M

+56.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$4.24M

+110.3%

Total Debt

$171.00K

-92.3%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$171.00K

-92.3%

Return on Assets

38.37%

N/A

Return on Invested Capital

1.79%

N/A

Free Cash Flow

-$1.05M

+24.0%

Operating Cash Flow

-$1.05M

+24.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
XBIOXenetic Biosciences, Inc.
$1.95-7.38%
QLGNQualigen Therapeutics, Inc.
$3.21+5.59%
ENSCEnsysce Biosciences, Inc.
$0.58+3.58%
SNGXSoligenix, Inc.
$0.35+2.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.62-0.33%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$102.51-7.26%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$45.57+7.16%
INTCIntel
$94.16-4.04%

Questions About ABPWW

What is the current price of Abpro?

Abpro is trading at $0.00 per share.

What is the 52-week range for Abpro?

Over the past 52 weeks, Abpro has traded between $0.00 and $0.03.

How much debt does Abpro have?

Abpro total debt is unavailable.

How much cash does Abpro have on hand?

Abpro does not have cash on hand data available.

What is Abpro’s dividend yield?

Abpro does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.